When will PET/MRI live up to its promise?
From its early days 10 years ago to the present, PET/MRI has developed from a modality simply comparable to PET/CT to one that is changing clinical practice and becoming a potentially “killer application” in prostate cancer. In a presentation at ECR 2021, researchers provided a review of recent developments in PET/MRI and considered (with apologies … Continue reading